15 Jul 2026
Gold Coated Glass Substrate Products Now Being Sold
Nanocrine’s technology makes live-cell communications visible in real time and has research applications in cancer metastasis, cellular senescence, immune system health, and neurodegenerative diseases.
In important recent developments, the Company has:
Hired Dr. Chung Liu, MD, PhD (most recently at the NIH), allowing the lab to operate 24/7 and significantly increasing experimental turnaround time.
Added two paying customers for its gold coated glass substrate products, showing that its thin film manufacturing capabilities generate standalone commercial revenue beyond the core imaging platform.
Two ongoing paid projects with the NIH, through the National Cancer Institute and the Institute of Translational Health Science.
Raised $550K toward its $750K bridge financing goal, with convertible notes still open to fill the remaining $200K gap (and eligible for the TEDCO matching grant).
Submitted a joint application with NCI for a $750K grant to support triple-negative breast cancer research; NCI is fully committed to the project, with allocated staff and other resources.
Entered a research partnership with Advanced In Vitro, a life science company specializing in preparing and preserving human tissue samples - particularly lung tissue - in a form that remains biologically active ex vivo.
Please contact Tony Coretto for more information or to arrange a meeting with Dr. Patrick Calhoun, Nanocrine's President and Chief Science Officer.